Target Details
| UniProt AC | Q02750 |
|---|---|
| Gene Symbol | MAP2K1 |
| Protein Name | Dual specificity mitogen-activated protein kinase kinase 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 543
- Clinical molecules 31
- Avg pChEMBL 7.3
KEGG Pathways (92)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Apelin signaling pathway
- Apoptosis
- Autophagy - animal
- B cell receptor signaling pathway
- Bladder cancer
- Breast cancer
- Cadherin signaling
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Cholinergic synapse
- Chronic myeloid leukemia
- Colorectal cancer
- Cushing syndrome
- EGFR tyrosine kinase inhibitor resistance
- Efferocytosis
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH secretion
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human T-cell leukemia virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- IgSF CAM signaling
- Influenza A
- Insulin signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- Melanoma
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oocyte meiosis
- Osteoclast differentiation
- Oxytocin signaling pathway
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Serotonergic synapse
- Signaling pathways regulating pluripotency of stem cells
- Sphingolipid signaling pathway
- T cell receptor signaling pathway
- TNF signaling pathway
- Thyroid cancer
- Thyroid hormone signaling pathway
- Toll-like receptor signaling pathway
- VEGF signaling pathway
- Vascular smooth muscle contraction
- Yersinia infection
- cAMP signaling pathway
- cGMP-PKG signaling pathway
- mTOR signaling pathway
Associated Diseases (5)
Active Molecules (543)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
LXLMKDYNQSTBFW
|
6.9 | IC50 | 3 | — | |
OQADNYQXVWLBPF
|
6.9 | IC50 | 3 | — | |
NUSWWDDYQRQFHO
|
6.9 | IC50 | 3 | — | |
LYADGAGFYYXXIO
|
6.9 | IC50 | 82 | — | |
NIZMUWJLIMKOIH
|
6.9 | IC50 | 2 | — | |
QJIMCCPZACTFFG
|
6.9 | IC50 | 2 | — | |
WXMCOSHTOJTIFK
|
6.9 | IC50 | 3 | — | |
LEYIHWDGZYQDAJ
|
6.9 | IC50 | 3 | — | |
UQNNJYLAPYGZBD
|
6.9 | Ki | 28 | — | |
JKPCWAYLRAJUNU
|
6.9 | IC50 | 3 | — | |
RZQMSENSUWINNW
|
6.9 | IC50 | 3 | — | |
WINHZLLDWRZWRT
|
6.9 | Kd | 201 | Yes | |
XCDDJSDCNNSGEH
|
6.9 | IC50 | 3 | — | |
CSAPGOSLBLMIPS
|
6.9 | IC50 | 3 | — | |
DVEXZJFMOKTQEZ
|
6.9 | IC50 | 4 | — | |
KJPIZTFQJJVHTA
|
6.9 | IC50 | 3 | — | |
PCTIECVOHLCQSU
|
6.9 | IC50 | 3 | — | |
UJBJWYNPUOLFIZ
|
6.9 | IC50 | 49 | — | |
WZZBNLYBHUDSHF
|
6.9 | IC50 | 2 | — | |
UEJXELMBDCXXAQ
|
6.8 | IC50 | 9 | — | |
LMMJFBMMJUMSJS
|
6.8 | IC50 | 5 | — | |
OGNYUTNQZVRGMN
|
6.8 | Ki | 16 | Yes | |
RBTJBGVGWLFOLY
|
6.8 | IC50 | 2 | — | |
VNDWQCSOSCCWIP
|
6.8 | IC50 | 39 | Yes | |
KPIKBRJPWVYBJZ
|
6.8 | IC50 | 3 | — | |
RVCKMZIQUFKZFD
|
6.8 | IC50 | 7 | — | |
VTZVVDZIRWWZJR
|
6.8 | IC50 | 3 | — | |
ADBKOQIERJLCFF
|
6.8 | IC50 | 2 | — | |
XIUWBGIKSXLESW
|
6.7 | IC50 | 4 | — | |
ZWVZORIKUNOTCS
|
6.7 | IC50 | 10 | Yes | |
CTKKHIGWHWTBQS
|
6.7 | IC50 | 2 | — | |
GETITGUMUDFBSL
|
6.7 | IC50 | 2 | — | |
OGRKOMKPSIJMLN
|
6.7 | IC50 | 2 | — | |
OLLSPENBOWNTBY
|
6.7 | IC50 | 3 | — | |
PFHWTBSZWRJPNA
|
6.7 | IC50 | 2 | — | |
SIBULRRGAQTCNA
|
6.7 | IC50 | 3 | — | |
GHWGOWZXFSETFX
|
6.7 | IC50 | 2 | — | |
JMFSLLJECHALSO
|
6.7 | IC50 | 3 | — | |
CLEGDJQQHUTCOW
|
6.7 | Ki | 43 | — | |
CLYHSTKBWHUKBD
|
6.7 | IC50 | 2 | Yes | |
FPFBRLFCFHRESP
|
6.7 | IC50 | 3 | — | |
GUBJNPWVIUFSTR
|
6.7 | Kd | 103 | — | |
OBHNTFJGFUEQCQ
|
6.7 | IC50 | 2 | — | |
SVEVUVOIIOZGQC
|
6.7 | IC50 | 2 | — | |
XUFLBSMTYMFOQH
|
6.7 | Ki | 43 | — | |
ACXODBAODQZCHM
|
6.7 | IC50 | 2 | — | |
AIENEURRWLHMLD
|
6.7 | IC50 | 3 | — | |
FORDRPJSYCKZQK
|
6.7 | IC50 | 2 | — | |
GBWNZODDBBIQEF
|
6.7 | IC50 | 2 | — | |
GTKJOUZHAZVXFH
|
6.7 | IC50 | 2 | — |